The research, carried out in mice, cells in the laboratory, and using publicly available data from patients with advanced melanoma before and after treatment with Nivolumab therapy, publishes today in the journal Immunity.

T cells are white blood cells that protect the body from harm from viruses, bacteria, and cancer cells, and explore their environments by using their T cell receptor (TCR) to recognize fragments—called antigens—of microbes or damaged cancer cells.

Read more...